1.Expression of MUC3, MUC5AC, MUC6 and Epidermal Growth Factor Receptor in Gallbladder Epithelium according to Gallstone Composition.
Hyo Jung KIM ; Jae Seon KIM ; Kyoung Oh KIM ; Ki Ho PARK ; Hyung Joon YIM ; Jin Yong KIM ; Jong Eun YEON ; Jong Jae PARK ; Jae Jeong SHIM ; Kwan Soo BYUN ; Young Tae BAK ; Chang Hong LEE
The Korean Journal of Gastroenterology 2003;42(4):330-336
BACKGROUND/AIMS: Gallbladder (GB) mucin is one of the key factors in the gallstone formation. However, there is little information about the diversity of mucin secretion according to the stone composition. Epidermal growth factor receptor (EGFR) functions in proliferation including mucin secreting goblet cell hyperplasia. We compared the expressions of MUC3, MUC5AC, MUC6 and EGFR in the GB epithelium with cholesterol gallstones (GB-chol) group and pigment gallstones (GB-pig group). METHODS: GBs from elective laparoscopic cholecystectomy for the gallstone disease were studied. Stone composition was analyzed by the spectrophotometer. Immunohistochemical stain was performed using each monoclonal antibody. The percentage of stained proportion was scored by the NIH image program and the results were compared between both groups. RESULTS: Total 20 patients were enrolled (10 patients with cholesterol gallstones, 10 patients with pigment gallstones). The percentages of stained proportion for MUC3, MUC5AC, and MUC6 were 42+/-27%, 31+/-15%, and 17+/-9%, respectively in GB-chol group and 32+/-22%, 33+/-23%, and 15+/-10%, respectively in GB-pig group (p>0.05). The expression of EGFR was 50% (5/10) in the GB-chol group and 80% (8/10) in the GB-pig group respectively. CONCLUSIONS: There was no difference in the expressions of MUC3, MUC5AC, and MUC6 between the two groups. Further studies are needed to elucidate the role of EGFR in the gallstore formation.
Bile Pigments/analysis
;
Cholelithiasis/chemistry/*metabolism
;
Cholesterol/analysis
;
Epithelium/metabolism
;
Gallbladder/*metabolism
;
Humans
;
Immunohistochemistry
;
Mucin 5AC
;
Mucin-3
;
Mucin-6
;
Mucins/*analysis
;
Receptor, Epidermal Growth Factor/*analysis
2.Whole exome sequencing in a pedigree with ankylosing spondylitis.
Wei-Fan REN ; Jing-Tao HU ; Yang GAO ; Wei-Bin DU ; He-Lou ZHANG ; Yi-Jiang WU ; Feng-Qing WU ; Le CHAI ; Ren-Fu QUAN
China Journal of Orthopaedics and Traumatology 2020;33(7):672-676
OBJECTIVE:
To choose the disease-causing gene in a Chinese pedigree with ankylosing spondylitis (AS) by whole-exome sequencing (WES), and provide theory basis for mechanism of disease.
METHODS:
Clinical data of AS pedigree were collected, including 2 males, the age were 48 and 18 years old, the course of disease were 23 and 4 years. Whole blood genomic DNA of AS was extracted to perform whole exome sequencing, the results were compared with human databases, common variations which had been reported were wiped out, then non synonymous single nucleotide variants(SNVs) from the family members were combined, and candidate genes was selected initially.
RESULTS:
Totally 80 G data was obtained from AS family with high quality.By comparing results between patient and normal subject, and filtering with number of biological database, the result showed heterozygous mutation of JAK2 gene 12 exon c.1709 A>G (p.Tyr570Cys) may be the potential disease-causing gene. The variant c.1151T>C of MUC3A gene may be one of the causes of intestinal symptoms in the family members.
CONCLUSION
It is feasible to find t candidate gene mutations of AS by Exon sequencing. The mutation c.1709 A>G in gene JAK2 identified by whole exome sequencing might be the pathogenic mutation in this AS pedigree.
Exome
;
Humans
;
Male
;
Mucin-3
;
Mutation
;
Pedigree
;
Spondylitis, Ankylosing
;
Whole Exome Sequencing
3.T-Cell Immunoglobulin Mucin 3 Expression on Tumor Infiltrating Lymphocytes as a Positive Prognosticator in Triple-Negative Breast Cancer.
Kyung Do BYUN ; Hyo Jun HWANG ; Ki Jae PARK ; Min Chan KIM ; Se Heon CHO ; Mi Ha JU ; Jin Hwa LEE ; Jin Sook JEONG
Journal of Breast Cancer 2018;21(4):406-414
PURPOSE: T-cell immunoglobulin and mucin domain-containing molecule 3 (TIM-3) is an emerging immune response molecule related to T-cell anergy. There has been tremendous interest in breast cancer targeting immune checkpoint molecules, especially in the triple-negative breast cancer (TNBC). This study was designed to investigate TIM-3 expression on tumor infiltrating lymphocytes (TILs), its relationships with clinicopathological para-meters and expression of programmed death receptor 1 (PD-1)/programmed death receptor ligand 1 (PD-L1), and its prognostic role. METHODS: Immunohistochemistry on tissue microarray blocks produced from 109 samples of invasive ductal carcinoma type TNBC was performed with antibodies toward TIM-3, PD-1, PD-L1 and breast cancer-related molecular markers. Associations between their expression and clinicopathological parameters as well as survival analyses were performed. RESULTS: TIM-3 was expressed in TILs from all 109 TNBCs, consisting of 17 cases ( < 5%), 31 cases (6%–25%), 48 cases (26%–50%), and 13 cases (>51%). High TIM-3 was significantly correlated with younger patients (p=0.0101), high TILs (p=0.0029), high tumor stage (p=0.0018), high PD-1 (p=0.0001) and high PD-L1 (p=0.0019), and tended to be associated with higher histologic grade, absence of extensive in situ components and microcalcification. High TIM-3 expression was significantly associated with a combinational immunophenotype group of high PD-L1 and high PD-1 (p < 0.0001). High TIM-3 demonstrated a significantly better disease-free survival (DFS) (p < 0.0001) and longer overall survival (OS) (p=0.0001), together with high TILs and high PD-1. In univariate survival analysis, high TIM-3 showed reduced relapse risk (p < 0.0001) and longer OS (p=0.0003), together with high PD-1 expression. In multivariate analysis, high TIM-3 was statistically significant in predicting prognosis, showing better DFS (hazard ratio [HR], 0.0994; 95% confidence interval [CI], 0.0296–0.3337; p=0.0002) and longer OS (HR, 0.1109; 95% CI, 0.0314–0.3912; p=0.0006). CONCLUSION: In this study, we demonstrate that TIM-3 expression is an independent positive prognostic factor in TNBC, despite its association with poor clinical and pathologic features.
Antibodies
;
Breast
;
Breast Neoplasms
;
Carcinoma, Ductal
;
Disease-Free Survival
;
Humans
;
Immunoglobulins*
;
Immunohistochemistry
;
Lymphocytes, Tumor-Infiltrating*
;
Mucin-3*
;
Mucins*
;
Multivariate Analysis
;
Prognosis
;
Recurrence
;
T-Lymphocytes*
;
Triple Negative Breast Neoplasms*
4.An Inverse Relationship between the Expression of the Gastric Tumor Suppressor RUNX3 and Infection with Helicobacter pylori in Gastric Epithelial Dysplasia.
Woo Chul CHUNG ; Sung Hoon JUNG ; Kyu Re JOO ; Min Ji KIM ; Gun Jung YOUN ; Yaeni KIM ; Joune Seup LEE ; Hyewon LEE ; Ji Han JUNG ; Yun Kyung LEE
Gut and Liver 2013;7(6):688-695
BACKGROUND/AIMS: This study was performed to determine the association between RUNX3 expression and Helicobacter pylori infection in premalignant gastric lesions. METHODS: We examined 107 patients with gastric epithelial dysplasia who had undergone endoscopic mucosal resection or submucosal dissection. All tissue samples were evaluated by RUNX3 staining and subclassified by immunophenotype. H. pylori infection in dysplastic lesions and the normal surrounding tissue was examined by silver staining, and cagA status was assessed by polymerase chain reaction. RESULTS: The loss of RUNX3 expression was observed in 62 cases (57.9%), and an association with H. pylori infection was found in 54 cases (50.5%). The infection rate with the cagA-positive H. pylori strain was 63.0%. In RUNX3-negative lesions, the rate of H. pylori infection (p=0.03) and the frequency of category 4 lesions (according to the revised Vienna classification) were high (p=0.02). In addition, the gastric mucin phenotype was predominant. In RUNX3-negative category 4 lesions, the rate of cagA-positive H. pylori infection rate was high but not significantly increased (p=0.08). CONCLUSIONS: Infection with H. pylori is associated with inactivation of RUNX3 in early gastric carcinogenesis. This mechanism was prominent in gastric cancer with a gastric mucin phenotype.
Adenoma/*chemistry
;
Aged
;
Antigens, Bacterial/genetics
;
Bacterial Proteins/genetics
;
Carcinoma/*chemistry
;
Cell Transformation, Neoplastic
;
Core Binding Factor Alpha 3 Subunit/*analysis
;
Female
;
Gastric Mucosa/*chemistry/pathology
;
Helicobacter Infections/*metabolism
;
Helicobacter pylori/*genetics
;
Humans
;
Male
;
Middle Aged
;
Mucin 5AC/analysis
;
Mucin-2/analysis
;
Mucin-6/analysis
;
Neprilysin/analysis
;
Phenotype
;
Precancerous Conditions/*chemistry/pathology
;
Stomach Neoplasms/*chemistry
5.Differentiation, Proliferative Index, and Caspase 3 Expression Rate in the Immunohistochemical Stains of Medulloblastoma as Prognostic Factors.
Sung Eun KIM ; Woo Ick YANG ; Tai Seung KIM
Korean Journal of Pathology 2001;35(6):536-543
BACKGROUND: Medulloblastoma is a highly malignant neuroepithelial tumor of the childhood, less frequently, of adults, located in the posterior cranial fossa. It shows multiple lines of differentiation, expressing neuronal, glial, mesenchymal and ectodermal markers. The prognostic significance of cell differentiation has been studied, but received little agreement. In highly malignant tumors, very high proliferative index has been demonstrated. A major contributor to cell loss in medulloblastoma is reported to be apoptosis. In medulloblstoma, a linear relation between apoptotic index and proliferative index has not been convincingly demonstrated. METHODS: We analyzed the immunohistochemical features, proliferative indices and apoptotic indices in medulloblastoma patients with regard to their clinical courses. Clinical features of 58 patients with medulloblastoma were reviewed. The presence of glial fibrillary acidic protein, synaptophysin, vimentin, and epithelial membrane antigen were examined with immunohistochemical method. The proliferative index (Ki-67) and caspase 3 expressing rate were calculated. RESULTS: There was no significant correlation between the prognosis and the degree of cell differentiation. The positive correlation was noted between proliferative index and apoptotic index in a tumor mass. CONCLUSIONS: Only proliferative index could be used as a prognostic factor.
Adult
;
Apoptosis
;
Caspase 3*
;
Caspases
;
Cell Differentiation
;
Coloring Agents*
;
Cranial Fossa, Posterior
;
Ectoderm
;
Glial Fibrillary Acidic Protein
;
Humans
;
Immunohistochemistry
;
Ki-67 Antigen
;
Medulloblastoma*
;
Mucin-1
;
Neoplasms, Neuroepithelial
;
Neurons
;
Prognosis
;
Synaptophysin
;
Vimentin
6.Dexamethasone protects airway epithelial cell line NCI-H292 against lipopolysaccharide induced endoplasmic reticulum stress and apoptosis.
Yan SHANG ; Fang WANG ; Chong BAI ; Yi HUANG ; Li-Jun ZHAO ; Xiao-Peng YAO ; Qiang LI ; Shu-Han SUN
Chinese Medical Journal 2011;124(1):38-44
BACKGROUNDEndoplasmic reticulum (ER) stress and ER stress-mediated apoptosis were reported to be involved in the pathogenesis of several diseases. In a recent study, it was reported that the ER stress pathway was activated in the lungs of lipopolysaccharide (LPS)-treated mice. It was also found that the C/EBP homologous protein (CHOP), an apoptosis-related molecule, played a key role in LPS-induced lung damage. The aim of this study was to verify whether LPS could activate the ER stress response in airway epithelial cells and which molecule was involved in the pathway. This study was also aimed at finding new reagents to protect the airway epithelial cells during LPS injury.
METHODSER stress markers were observed in LPS-incubated NCI-H292 cells. SiRNA-MUC5AC was transfected into NCI-H292 cells. The effects of dexamethasone and erythromycin were observed in LPS-induced NCI-H292 cells.
RESULTSLPS incubation increased the expression of ER stress markers at the protein and mRNA levels. The knockout of MUC5AC in cells attenuated the increase in ER stress markers after incubation with LPS. Dexamethasone and erythromycin decreased caspase-3 activity in LPS-induced NCI-H292 cells.
CONCLUSIONSLPS may activate ER stress through the overexpression of MUC5AC. Dexamethasone may protect human airway epithelial cells against ER stress-related apoptosis by attenuating the overload of MUC5AC.
Animals ; Apoptosis ; drug effects ; genetics ; Caspase 3 ; metabolism ; Cell Line, Tumor ; Dexamethasone ; pharmacology ; Endoplasmic Reticulum ; drug effects ; metabolism ; Erythromycin ; pharmacology ; Humans ; Lipopolysaccharides ; pharmacology ; Mice ; Mucin 5AC ; genetics ; metabolism ; RNA, Small Interfering
7.Molecular mechanism of interleukin-13-induced mucus hypersecretion in rat airway.
De-peng JIANG ; Victor P KOLOSOV ; Juliy M PERELMAN ; Xiang-dong ZHOU
Journal of Southern Medical University 2011;31(1):73-76
OBJECTIVETo investigate the effect of interleukin-13 (IL-13) on mucus secretion in vivo and the possible mechanism.
METHODSThe SD rats were randomly divided into control group, IL-13 group and IL-13 plus SP600125 group. The phosphorylation of extracellular signal-regulated kinase 1/2 (ERK1/2), c-Jun N-terminal kinase 1/2 (JNK1/2) and the level of MUC5AC in the lung tissues were examined using Western blotting. RT-PCR was performed to examine the mRNA level of STAT4 and STAT6, and electrophoretic mobility shift assays (EMSA) was used to detect the DNA-binding activities of Forkhead box a2 (FOXA2) and activator protein-1 (AP-1).
RESULTSIL-13 caused a significant increase in MUC5AC and p-JNK1/2 expression, but did not affect the phosphorylation of ERK1/2. The expression of MUC5AC was attenuated after treatment with SP600125. A significant increase in STAT6 was observed in IL-13 group compared with that in the control group, whereas the expression of STAT4 mRNA was not significantly affected. The DNA-binding activity of FOXA2 was down-regulated after IL-13 exposure, which did not affect the DNA-binding activity of AP-1.
CONCLUSIONIL-13 down-regulates mucus secretion via STAT6-FOXA2 pathway in vitro.
Animals ; Bronchi ; secretion ; Female ; Hepatocyte Nuclear Factor 3-beta ; genetics ; metabolism ; Interleukin-13 ; pharmacology ; Male ; Mucin 5AC ; metabolism ; Mucus ; secretion ; RNA, Messenger ; genetics ; metabolism ; Random Allocation ; Rats ; Rats, Sprague-Dawley ; STAT6 Transcription Factor ; genetics ; metabolism ; Signal Transduction ; drug effects
8.Expression of galectin-3 and Sambucus nigra agglutinin and its clinicopathological significance in benign and malignant lesions of breast.
Gannong CHEN ; Qiongyan ZOU ; Zhulin YANG
Journal of Central South University(Medical Sciences) 2010;35(6):584-589
OBJECTIVE:
To detect the expression of galectin-3 (gal-3) and Sambucus nigra agglutinin (SNA) and determine their clinicopathological significance in breast cancers and benign breast lesions.
METHODS:
Envison immunohistochemistry for staining gal-3 expression, and ABC affinity-cytochemistry to detect SNA expression were used in paraffin-embedded slides from specimens of breast cancers (n=60) and benign lesions (n=30).
RESULTS:
The positive rates and scoring means of gal-3 and SNA were significantly higher in breast cancer (48.3%, 2.07 +/- 2.25, 2.12 +/- 2.26) than those in benign lesions (26.7%, 1.03 +/- 1.63, 1.07 +/- 1.59, P < 0.05). The scoring means of gal-3 and SNA expression were significantly lower in the positive cases of estrogen receptor (ER) and the negative ones of CA15-3 than those in the negative cases and the positive ones (P < 0.05).The survival analysis of Kaplan-Meier showed the 5-year survival rate and mean survival period were significantly lower in the gal-3 or SNA expression positive cases than those in the negative cases of breast cancer (P<0.01).
CONCLUSION
The expressive level of gal-3 and SNA lectins might have important effect on the carcinogenesis, progression and biologic behaviors of breast cancer. The positive cases of gal-3 and /or SNA expression might have poor prognosis.
Adolescent
;
Adult
;
Aged
;
Breast Neoplasms
;
metabolism
;
pathology
;
Female
;
Fibrocystic Breast Disease
;
metabolism
;
pathology
;
Galectin 3
;
genetics
;
metabolism
;
Humans
;
Middle Aged
;
Mucin-1
;
metabolism
;
Plant Lectins
;
genetics
;
metabolism
;
Prognosis
;
Receptors, Estrogen
;
metabolism
;
Ribosome Inactivating Proteins
;
genetics
;
metabolism
;
Young Adult
9.Effects of Scutellarin on MUC5AC Mucin Production Induced by Human Neutrophil Elastase or Interleukin 13 on Airway Epithelial Cells.
De Peng JIANG ; Juliy M PERELMAN ; Victor P KOLOSOV ; Xiang Dong ZHOU
Journal of Korean Medical Science 2011;26(6):778-784
Scutellarin is a flavonoid extracted from a traditional Chinese herb, Erigeron breviscapus. The present study investigated the effect of scutellarin on MUC5AC mucin production and the possible mechanism. Human bronchial epithelial 16 (HBE16) cells were pretreated with scutellarin for 60 min, and then exposed to human neutrophil elastase (HNE) or interleukin (IL)-13 for 12 hr. RT-PCR and ELISA were performed to measure the amount of MUC5AC mucin production. The results showed that scutellarin inhibited MUC5AC expression both in mRNA and protein level induced by HNE in a concentration-dependent manner. However, scutellarin failed to inhibit MUC5AC mucin production induced by IL-13. To investigate the intracellular mechanisms associated with the effect of scutellarin on MUC5AC mucin production, western blotting was carried out to examine the phosphorylation of protein kinase C (PKC), signal transducer and activator of transcription 6 (STAT6) and extracellular signal-regulated kinase 1/2 (ERK1/2). The phosphorylation of PKC and ERK1/2 was attenuated after treatment with scutellarin, whereas STAT6 was not significantly affected. Therefore, it is suggested that scutellarin down-regulates MUC5AC mucin production on HBE16 cells via ERK-dependent and PKC-dependent pathways.
Apigenin/chemistry/*pharmacology
;
Cells, Cultured
;
Dose-Response Relationship, Drug
;
Down-Regulation
;
Epithelial Cells/*drug effects/metabolism
;
Erigeron/chemistry
;
Glucuronic Acids/chemistry/*pharmacology
;
Humans
;
Interleukin-13/*pharmacology
;
Leukocyte Elastase/*pharmacology
;
Mitogen-Activated Protein Kinase 1/metabolism
;
Mitogen-Activated Protein Kinase 3/metabolism
;
Mucin 5AC/genetics/*metabolism
;
Phosphorylation
;
Protein Kinase C/metabolism
;
Respiratory Mucosa/drug effects/*metabolism
;
STAT6 Transcription Factor/metabolism
;
Signal Transduction
10.Role of extracellular signal-regulated kinase 1/2 in cigarette smoke-induced mucus hypersecretion in a rat model.
Jun XIAO ; Ke WANG ; Yu-Lin FENG ; Xue-Rong CHEN ; Dan XU ; Ming-Ke ZHANG
Chinese Medical Journal 2011;124(20):3327-3333
BACKGROUNDAirway mucus hypersecretion is an important pathophysiological feature of chronic obstructive pulmonary disease, which is closely associated with cigarette smoking. However, the signal transduction pathway from the cell surface to the nucleus through which cigarette smoke causes upregulation of mucin gene expression is not well known. This study was designed to investigate the role of extracellular signal-regulated Kinase 1/2 (ERK 1/2) in airway mucus hypersecretion induced by cigarette smoke in rats.
METHODSA rat model of airway mucus hypersecretion was induced by exposure to cigarette smoke for 4 weeks.Rats exposed to inhalation of cigarette smoke or normal saline were given an intraperitoneal injection of U0126, a specific MEK1 kinase inhibitor, at doses of 0.25 mg/kg, 0.5 mg/kg and 1 mg/kg for 14 days. Expression of MUC5AC mRNA and protein, ERK 1/2 and phosphorylated-ERK 1/2 (p-ERK 1/2) were detected by RT-PCR, immunohistochemistry and Western blotting.
RESULTSCigarette smoke significantly increased airway goblet cells metaplasia, induced the overexpression of MUC5AC mRNA and protein in bronchial epithelia, and increased the ratio of p-ERK 1/2 and ERK 1/2. U0126 significantly attentuated the expression of MUC5AC mRNA and protein induced by cigarette smoke (P < 0.05). Moreover, there was a significant positive correlation between the ratio of p-ERK1/2 to ERK1/2 and the expression of MUC5AC mRNA and protein (P < 0.05).
CONCLUSIONSInhibition of ERK 1/2 by U0126 decreased the ratio of p-ERK 1/2 to ERK 1/2 and expression of MUC5AC mRNA and protein. ERK 1/2 may play an essential role in cigarette smoke-induced mucus hypersecretion in vivo.
Animals ; Blotting, Western ; Bronchi ; cytology ; metabolism ; Goblet Cells ; drug effects ; metabolism ; Immunohistochemistry ; Lung ; drug effects ; metabolism ; Mitogen-Activated Protein Kinase 1 ; genetics ; metabolism ; Mitogen-Activated Protein Kinase 3 ; genetics ; metabolism ; Mucin 5AC ; genetics ; metabolism ; Phosphorylation ; drug effects ; Rats ; Respiratory Mucosa ; secretion ; Reverse Transcriptase Polymerase Chain Reaction ; Smoking ; adverse effects